Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace.
Revenue (Most Recent Fiscal Year) | $278.42M |
Net Income (Most Recent Fiscal Year) | $14.52M |
PE Ratio (Current Year Earnings Estimate) | 46.72 |
PE Ratio (Trailing 12 Months) | 46.07 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 2.96 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.87 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 20.73 |
Pre-Tax Margin (Trailing 12 Months) | 6.58% |
Net Margin (Trailing 12 Months) | 5.21% |
Return on Equity (Trailing 12 Months) | 6.47% |
Return on Assets (Trailing 12 Months) | 5.02% |
Current Ratio (Most Recent Fiscal Quarter) | 2.29 |
Quick Ratio (Most Recent Fiscal Quarter) | 1.98 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.11 |
Inventory Turnover (Trailing 12 Months) | 12.20 |
Book Value per Share (Most Recent Fiscal Quarter) | $30.79 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.64 |
Earnings per Share (Most Recent Fiscal Year) | $2.29 |
Diluted Earnings per Share (Trailing 12 Months) | $1.56 |
Exchange | NASDAQ |
Sector | Industrials |
Industry | Industrial Distribution |
Common Shares Outstanding | 9.32M |
Free Float | 9.10M |
Market Capitalization | $824.15M |
Average Volume (Last 20 Days) | 0.13M |
Beta (Past 60 Months) | 0.69 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 2.30% |
Percentage Held By Institutions (Latest 13F Reports) | 98.34% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |